Hospital Universitario Quirónsalud Madrid

Pozuelo de Alarcón, Madrid 28223

0 studies enrolling now · 2 studies all time

What they study most

Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer, Metastatic Cervical Cancer, Mild to Moderate Alzheimer's Disease

Studies at this site

• GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD) — Completed
• HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib — Stopped early